Intravenous Drug Abuse
3
0
0
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Harm Reduction Standard Of Care
Research Leaders
7 sponsors active, led by University of Colorado, Denver
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 3 trials
100.0%
+13.4% vs benchmark
33%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (3)
Pre-exposure Prophylaxis (PrEP) for People Who Inject Drugs (PWID)
Psychoeducation Reaches HCV-infected Methadone/Buprenorphine Substituted Patients in Standard Antiviral Treatment
Reducing Health Problems Associated With Injection Drug Use
Research Network
Common Treatments
- Harm Reduction Standard Of Care1
- Skin And Needle Hygiene Intervention1
- Psychoeducation1
- Prep Uptakeadherence Intervention1
- No Intervention Assessmentonly Condition1
Active Sponsors
- University of Colorado, Denver1
- Boston University1
- Universitätsklinikum Hamburg-Eppendorf1
- University of Northern Colorado1
- Butler Hospital1
Top Investigators
Boston University
University of Northern Colorado
Praxiszentrum Kaiserdamm
Related Conditions
- Hiv Infections1
- Chronic Hepatitis C1